Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.290
0.00 (0.00%)
Nov 5, 2024, 11:14 AM EST - Market open
Nuvation Bio Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Nuvation Bio stock have an average target of 6.17, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 169.43% from the current stock price of 2.29.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nuvation Bio stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $5 | Buy | Reiterates | $5 | +118.34% | Oct 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +205.68% | Sep 16, 2024 |
| Wedbush | Wedbush | Buy Reiterates $5 | Buy | Reiterates | $5 | +118.34% | Sep 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $5 | Buy | Reiterates | $5 | +118.34% | Aug 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +249.34% | Jul 17, 2024 |
Financial Forecast
Revenue This Year
1.46M
Revenue Next Year
1.66M
from 1.46M
Increased by 13.99%
EPS This Year
-2.17
from -0.35
EPS Next Year
-0.61
from -2.17
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.5M | 3.5M | 107.5M | ||
| Avg | 1.5M | 1.7M | 67.3M | ||
| Low | 1.4M | n/a | 29.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 137.7% | 6,368.1% | ||
| Avg | - | 14.0% | 3,950.1% | ||
| Low | - | - | 1,645.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.97 | -0.48 | -0.59 | ||
| Avg | -2.17 | -0.61 | -0.58 | ||
| Low | -2.27 | -0.73 | -0.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.